A Study of Sweat Testing Using a Quantitative Patch
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- Cystic Fibrosis
- 发起方
- Polychrome Medical, Inc.
- 入组人数
- 170
- 试验地点
- 3
- 主要终点
- sweat chloride value
- 状态
- 已完成
- 最后更新
- 7年前
概览
简要总结
The primary aim of the study is to determine if the CF Quantum Sweat Test provides sweat chloride results that are equivalent to the results from traditional sweat testing. The secondary aim of the study is to assess the quantity not sufficient rate of the CF Quantum Sweat Test compared to traditional sweat testing.
详细描述
All 50 states and the District of Columbia are performing newborn screening for cystic fibrosis (CF). Infants who have a positive newborn screen require follow-up with a sweat test. Gibson-Cooke Quantitative Pilocarpine Iontophoresis (GCQPIT) requires collecting sweat in microbore tubing or on gauze/filter paper and analyzing sweat using a chloridometer. This test has many difficulties including specimens that are quantity not sufficient (QNS), many steps of pipetting solutions in the laboratory, and the need for a chloridometer to analyze sweat chloride concentration. The only manufacturer of a chloridometer has ceased production of this instrument. The CF Quantum® Sweat Test System (CFQT) overcomes all of the difficulties of GCQPIT. This pilot study will determine if the CFQT provides results that are equivalent to GCQPIT.
研究者
入排标准
入选标准
- •clinical diagnosis of cystic fibrosis
- •patients who require a sweat test
排除标准
- •Infants less than 48 hours of age
- •Patient is receiving oxygen by open delivery
- •collection site has diffuse inflammation or rash
结局指标
主要结局
sweat chloride value
时间窗: once, at enrollment (baseline)
Sweat chloride measurements obtained by GCQPIT and CFQT
次要结局
- QNS rate(once, at enrollment (baseline))